4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000143
Chairperson & CEO sold 9,500 shares at an average $501.39 ($4,763,172)
- Chairperson & CEO acquired 9,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
ROTHBLATT MARTINE A · Chairperson & CEO
Table I: Non-derivative
9 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-09-16 | Exercise or conversion : show line 1 in the form 10b5-1 | +9,500 | $117.76 | $1,118,720 | 333,943 | I |
| 2026-09-16 | Sale : show line 2 in the form 10b5-1 | −2,080 | $498.45 | $1,036,777 | 331,863 | I |
| 2026-09-16 | Sale : show line 3 in the form 10b5-1 | −1,220 | $499.15 | $608,966 | 330,643 | I |
| 2026-09-16 | Sale : show line 4 in the form 10b5-1 | −492 | $500.19 | $246,096 | 330,151 | I |
| 2026-09-16 | Sale : show line 5 in the form 10b5-1 | −708 | $501.52 | $355,077 | 329,443 | I |
| 2026-09-16 | Sale : show line 6 in the form 10b5-1 | −2,160 | $502.44 | $1,085,272 | 327,283 | I |
| 2026-09-16 | Sale : show line 7 in the form 10b5-1 | −1,538 | $503.53 | $774,429 | 325,745 | I |
| 2026-09-16 | Sale : show line 8 in the form 10b5-1 | −1,182 | $504.17 | $595,932 | 324,563 | I |
| 2026-09-16 | Sale : show line 9 in the form 10b5-1 | −120 | $505.20 | $60,624 | 324,443 | I |
| Open-market sales · 9,500 sh · avg $501.39 · $4,763,172 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-09-16 | Exercise or conversion : show line 10 in the form 10b5-1 Stock Option | −9,500 | 423,410 | I |
Loading xslF345X06/primarydocument.xml…